featured
Cumulative Exposure to Immunomodulators and Biologics and the Risk of Cervical Neoplasia in Women With IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease
Aliment. Pharmacol. Ther. 2023 May 23;[EPub Ahead of Print], JE Kreijne, RL Goetgebuer, NS Erler, NK De Boer, AG Siebers, G Dijkstra, FA van Kemenade, F Hoentjen, B Oldenburg, AE van der Meulen, CIJ Ponsioen, MJ Pierik, CJ van der Woude, AC de VriesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.